Seminars in Nephrology
Volume 28, Issue 3 , Pages 266-278, May 2008

Bypassing Vasopressin Receptor Signaling Pathways in Nephrogenic Diabetes Insipidus

Massachusetts General Hospital-Center for Systems Biology, Program in Membrane Biology and Nephrology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by National Institutes of Health grant DK38452. Also supported by a Young Investigator Award from the National Kidney Foundation (R.B.), a Swiss Fondation Suisse pour les Bourses en Médicine et Biologie Fellowship and an Executive Committee on Research Fellowship from Massachusetts General Hospital (U.H.), a National Institutes of Health KO8 grant DK075940-01 (H.A.J.L.), and a doctoral level postgraduate scholarship from National Sciences and Engineering Council of Canada (P.N.). The Microscopy Core facility of the MGH Program in Membrane Biology receives additional support from the Boston Area Diabetes and Endocrinology Research Center (DK57521) and the Center for the Study of Inflammatory Bowel Disease (DK43341).

PII: S0270-9295(08)00054-5

doi:10.1016/j.semnephrol.2008.03.010

Seminars in Nephrology
Volume 28, Issue 3 , Pages 266-278, May 2008

Article Tools

* Image Usage & Resolution